BONESUPPORT AB is a Scandinavian orthobiologics company that develops and markets CERAMENT®, an innovative range of radiopaque injectable osteoconductive and drug-eluting bioceramic products that have a proven ability to heal defects by remodeling to host bone in six to twelve months.
Our products are effective in treating patients with fractures and bone voids caused by trauma, infection, disease or related surgery.
Latest Press Release
Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)
31/03/2021
Issue and repurchase of series C shares for share saving program
15/03/2021
BONESUPPORT’s FDA notification: Approval on DeNovo pathway for CERAMENT G will require additional data and clarifications
27/02/2021